Guterman L R, Jenkins J A, Borchers D J, Rodriguez R, Hopkins L N
Department of Neurosurgery, State University of New York at Buffalo, School of Medicine and Biomedical Sciences, USA.
Curr Opin Neurol. 1996 Feb;9(1):57-61.
Cerebrovascular disease continues to be a major source of morbidity and mortality in our aging population. Endovascular therapy for the treatment of cerebral aneurysms and associated vasospasm is gaining credibility. Some arteriovenous malformations considered inoperable in the past can now be successfully treated using multimodality therapy. Quantitative measurement of cerebral blood flow is helping to identify patients at risk of ischemic events and defining new guidelines for intervention. New noninvasive imaging modalities may replace conventional angiography for surgical disease. Advances in technology continue to improve our ability to treat cerebrovascular disease prior to irreversible ischemic events.
在我们的老龄人口中,脑血管疾病仍然是发病和死亡的主要原因。用于治疗脑动脉瘤及相关血管痉挛的血管内治疗正逐渐获得认可。一些过去被认为无法手术治疗的动静脉畸形现在可以通过多模态治疗成功治愈。脑血流量的定量测量有助于识别有缺血事件风险的患者,并为干预制定新的指导方针。新的非侵入性成像方式可能会取代传统血管造影用于手术疾病的诊断。技术进步不断提高我们在不可逆缺血事件发生之前治疗脑血管疾病的能力。